Balancing Diversity and Effectiveness: Industry Feedback on FDA’s DAP Guidance

The medical device industry supports the FDA's draft guidance document on Diversity Action Plans but seeks flexibility and clarity, especially for international and IVD trials, and recommends using real-world data for postmarket studies.